Emerging infectious diseases (EIDs) represent a dynamic and evolving threat to global public health. These diseases, which are newly identified or reemerging with increased incidence or geographic range, pose significant challenges to healthcare systems and society at large. Factors such as population growth, urbanization, international travel, and climate change contribute to the emergence and spread of EIDs. The rapid globalization of trade and travel further facilitates the dissemination of infectious agents across borders, amplifying the risk of pandemics. Recent examples of EIDs include the Zika virus, Ebola virus disease, and COVID-19, each highlighting the potential for previously unknown pathogens to cause widespread illness and societal disruption. Addressing the complex drivers of EIDs requires a multifaceted approach, encompassing surveillance, early detection, rapid response, vaccination, antimicrobial stewardship, and international collaboration to mitigate their impact on human health and well-being.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain